National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

From the 10/15/2021 release of VAERS data:

Found 9 cases where Location is Vermont and Onset Interval is 0 and Vaccine targets COVID-19 (COVID19) and Serious

Table

   
AgeCountPercent
17-44 Years444.44%
44-65 Years111.11%
65-75 Years111.11%
75+ Years111.11%
Unknown222.22%
TOTAL9100%



Case Details

VAERS ID: 1114252 (history)  
Form: Version 2.0  
Age:   
Sex: Male  
Location: Vermont  
Vaccinated:2021-03-02
Onset:2021-03-02
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-03-19
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 022M20A / 1 - / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Diverticulum, Vaccination site pain
SMQs:

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: No adverse event (No reported medical history)
Allergies:
Diagnostic Lab Data:
CDC Split Type: USMODERNATX, INC.MOD20210

Write-up: diverticulosis; pain at injection site; A spontaneous report was received from a consumer concerning a 70 year old male patient, who was received Moderna''s COVID-19 vaccine(mRNA-1273) and experienced diverticulosis and pain at injection site. The patients medical history was not provided. No relevant Concomitant medications were reported. On 02 mar 2021,prior to the onset of events, the Patient received the first of two planned dose of mRNA-1273(Lot number: 022M20A ) vaccine intramuscularly for prophylaxis of COVID-19 infection. On 02 mar 2021, patient experienced pain at the injection site and diverticulosis. The patient was admitted to Hospital on 02 mar 2021. No surgery performed. Discharged on 04 mar 2021.The event caused two days of hospitalization. Treatment for the event included Amoxicillin . Action taken with the second dose of mRNA-1273 in response to the event was not reported. The outcome of the event diverticulosis and pain at injection site was not provided.; Reporter''s Comments: Based on the current available information and temporal association between the use of the product and the start date of the events, a causal relationship cannot be excluded.


VAERS ID: 1135728 (history)  
Form: Version 2.0  
Age:   
Sex: Female  
Location: Vermont  
Vaccinated:2021-03-16
Onset:2021-03-16
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-03-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / UNK - / OT

Administered by: Unknown       Purchased by: ?
Symptoms: Anaphylactic reaction
SMQs:, Anaphylactic reaction (narrow), Anaphylactic/anaphylactoid shock conditions (narrow), Hypersensitivity (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: No adverse reaction
Allergies:
Diagnostic Lab Data:
CDC Split Type: USMODERNATX, INC.MOD20210

Write-up: Anaphylactic response; A spontaneous report was received from a consumer concerning a female patient of unspecified age, who received Moderna''s COVID-19 vaccine (mRNA-1273) and experienced an anaphylactic reaction. The patient''s medical history was not provided. Concomitant medications were not provided. On 16 Mar 2021, a few moments prior to the onset of the events, the patient received their first of the two planned doses of mRNA-1273 (Batch number: unknown) for prophylaxis of COVID-19 infection. On 16 Mar 2021, the patient had an anaphylactic reaction and had to be hospitalized. She was still in the hospital as of 17 Mar 2021. Treatment information mentions 4 epinephrine pens and diphenhydramine. Action taken with mRNA-1273 in response to the events was unknown. The outcome of the events, anaphylactic reaction, was considered as unknown.; Reporter''s Comments: Based on the current available information and temporal association between the use of the product and the start date of the event, a causal relationship cannot be excluded. Further information has been requested


VAERS ID: 1136603 (history)  
Form: Version 2.0  
Age: 44.0  
Sex: Female  
Location: Vermont  
Vaccinated:2021-03-09
Onset:2021-03-09
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-03-26
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EN6199 / 1 LA / -

Administered by: Pharmacy       Purchased by: ?
Symptoms: Dizziness, Dysphagia, Dyspnoea, Hypoaesthesia oral, Movement disorder
SMQs:, Anaphylactic reaction (broad), Anticholinergic syndrome (broad), Akathisia (broad), Dyskinesia (broad), Dystonia (broad), Parkinson-like events (broad), Oropharyngeal conditions (excl neoplasms, infections and allergies) (narrow), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Guillain-Barre syndrome (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (broad), Cardiomyopathy (broad), Vestibular disorders (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? No
Previous Vaccinations:
Other Medications: LORATADINE; METFORMIN; PAROXETINE; WELLBUTRIN
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Allergic reaction to bee sting; Depression; Pre-diabetes
Allergies:
Diagnostic Lab Data:
CDC Split Type: USPFIZER INC2021263134

Write-up: Dizziness; numb tongue; difficulty swallowing; difficulty breathing; inability to move arms and legs; This is a spontaneous report from a contactable consumer. A 44-years-old female patient received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, lot number EN6199 and expiration date unknown), via an unspecified route of administration in the left arm on 09Mar2021 at 15:00 as a single dose for COVID-19 immunization. Medical history included depression, pre-diabetes and known allergies: bee stings. Concomitant medications included loratadine (LORATADINE), metformin (METFORMIN), paroxetine (PAROXETINE), and bupropion hydrochloride (WELLBUTRIN), and "Mul". The patient had no other vaccine in four weeks. On 09Mar2021 at 15:15, The patient experienced dizziness, numb tongue, difficulty swallowing, difficulty breathing, and inability to move arms and legs. The patient had no COVID prior vaccination and had not tested post vaccination. Therapeutic measures were taken as a result of the events which included Epinephrine, ER treatment, and Prednisone. The outcome of the events was resolving. The events resulted in: Emergency room/department or urgent care, Life threatening illness (immediate risk of death from the event).


VAERS ID: 1255242 (history)  
Form: Version 2.0  
Age: 40.0  
Sex: Female  
Location: Vermont  
Vaccinated:2020-12-19
Onset:2020-12-19
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-04-25
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / 1 RA / OT

Administered by: Private       Purchased by: ?
Symptoms: Asthenia, Blood follicle stimulating hormone, Blood follicle stimulating hormone increased, Chills, Hot flush, Infertility female, Migraine, Nausea, Ovarian disorder, Pyrexia, SARS-CoV-2 test, Ultrasound scan, Vertigo, Vomiting
SMQs:, Acute pancreatitis (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Guillain-Barre syndrome (broad), Gastrointestinal nonspecific symptoms and therapeutic procedures (narrow), Vestibular disorders (narrow), Fertility disorders (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), COVID-19 (broad), Sexual dysfunction (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: WELLBUTRIN; LOESTRIN
Current Illness:
Preexisting Conditions: Medical History/Concurrent Conditions: Asthma (other medical history: Eosinophilic esophagitis, asthma); Eosinophilic esophagitis (other medical history: Eosinophilic esophagitis, asthma)
Allergies:
Diagnostic Lab Data: Test Name: FSH; Result Unstructured Data: Test Result:Unknown results; Comments: previous values; Test Date: 20201219; Test Name: FSH; Result Unstructured Data: Test Result:skyrocketed from previous values; Comments: They obtained an FSH level and it had skyrocketed from previous values not long before my ovaries had shrunk in size by approximately half; Test Date: 20210314; Test Name: nasal swab/Covid test; Test Result: Negative ; Test Date: 20201219; Test Name: ultrasound; Result Unstructured Data: Test Result:ovaries had shrunk in size; Comments: ovaries had shrunk in size by approximately half
CDC Split Type: USPFIZER INC2021392945

Write-up: Diminished ovarian reserve/diminished reserve; fever; chills; hot flashes; nausea; vomiting; migraine headache; vertigo; weakness; They obtained an FSH level and it had skyrocketed from previous values not long before; my ovaries had shrunk in size by approximately half; This is a spontaneous report from a contactable nurse (patient). A 40-years-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection), first dose via intramuscular, administered in right arm on 19Dec2020 09:30 at a single dose (lot number and expiry date were not reported); and then received the second dose on 02Jan2021 09:30 (lot number and expiry date not reported), intramuscularly administered in right arm as a single dose; for COVID-19 immunisation. Medical history included eosinophilic esophagitis and asthma. The patient had no known allergies. The patient was not pregnant at the time of the report and vaccination. The patient had no covid prior vaccination. Concomitant medications which were taken in two weeks prior to vaccination included bupropion hydrochloride (WELLBUTRIN) and ethinylestradiol, norethisterone acetate (LOESTRIN), taken for an unspecified indication, start and stop date were not reported. The patient had no other vaccine in four weeks. On 19Dec2020, the patient experienced diminished ovarian reserve. Patient stated that she was extremely symptomatic after both vaccines and starting on 19Dec2020 had experienced fever, chills, hot flashes, nausea, vomiting, migraine headache, vertigo and weakness. The hot flashes persisted and worsened after each subsequent vaccine, prompting her to go to my MD. They obtained an FSH level on 19Dec2020 and it had skyrocketed from previous values (dates unspecified; unknown results) not long before. An ultrasound on 19Dec2020, showed that her ovaries had shrunk in size by approximately half and she had diminished reserve. Patient was now on supplemental hormones and will be for many years to come as she was only 40. Patient know the vaccine caused this. It was too great of a coincidence. Adverse events resulted in doctor or other healthcare professional office/clinic visit, disability or permanent damage. As a result of the events reported patient was now on hormonal replacement therapy. The patient was tested for covid post vaccination which included nasal swab/Covid test on 14Mar2021 as negative. The outcome of the events reported was not recovered. Information about lot/batch number has been requested.; Sender''s Comments: A possible contributory effect of suspect BNT162B2 on reported events cannot be excluded, for events fever, chills, hot flashes, nausea, vomiting, migraine headache, vertigo and weakness, conversely the suspect drug is considered very unlikely related for other gynecological disturbances. The impact of this report on the benefit/risk profile of the Pfizer drug is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to Committees and Investigators, as appropriate.


VAERS ID: 1361961 (history)  
Form: Version 2.0  
Age: 96.0  
Sex: Female  
Location: Vermont  
Vaccinated:2021-05-07
Onset:2021-05-07
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-05-30
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (JANSSEN)) / JANSSEN 1808982 / 1 LA / IM

Administered by: Other       Purchased by: ?
Symptoms: Brain natriuretic peptide, Culture urine positive, Death, Decreased appetite, Diet refusal, Fatigue, Feeling hot, Full blood count, Metabolic function test, Nervousness, Oedema peripheral, Pain, Pleural effusion, Somnolence, Urinary tract infection
SMQs:, Cardiac failure (broad), Angioedema (broad), Systemic lupus erythematosus (broad), Anticholinergic syndrome (broad), Dementia (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), Hypoglycaemia (broad), Infective pneumonia (broad)

Life Threatening? No
Birth Defect? No
Died? Yes
   Date died: 2021-05-29
   Days after onset: 22
Permanent Disability? No
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Eliquis 2.5 mg BID Lasix 40 mg QD KCL 10 meq 3 AM/week gabapentin 300 mg QHS magnesium 120 mg BID Vitamin B12 500 mcg QAM Vitamin B2 100 mg QAM PreserVision AREDS 1 BID Vitamin D3 1000 IU QHS
Current Illness: none
Preexisting Conditions: A-FIB well controlled CHF well controlled TIAs Macular Degeneration
Allergies: Reaction to all medications below is nausea and vomiting codeine bactrim macrobid tramadol
Diagnostic Lab Data: ProBMP metabolic panel urine for C&S CBC
CDC Split Type:

Write-up: profound exhaustion, unable to stay awake even with stimulation, severe anorexia - unwilling to eat pleural effusion +4 leg edema UTI felt like she was shaking internally (found it painful) felt hot (not common) body aches outcome=death


VAERS ID: 1371830 (history)  
Form: Version 2.0  
Age: 66.0  
Sex: Male  
Location: Vermont  
Vaccinated:2021-04-09
Onset:2021-04-09
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-06-03
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH - / UNK - / -

Administered by: Private       Purchased by: ?
Symptoms: Condition aggravated, Upper respiratory tract infection
SMQs:

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? Yes
Office Visit? No
ER Visit? No
ER or Doctor Visit? No
Hospitalized? Yes, 2 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: albuterol, acetylcycsteine, cetirizine, daliresp, eliquis, famotidine, furosemide, lantus, jardience, losartan, metformin, prednisone, crestor,
Current Illness: URI, COPD exacerbation
Preexisting Conditions: COPD, CAD. DMII, obesity, HTN, hyperlipidemia
Allergies: nkda
Diagnostic Lab Data:
CDC Split Type:

Write-up: presented to ED and was admitted to med center same day as 2nd COVID vaccine. Patient was exhibiting s/sx of URI at time of vaccine which worsened. admission 04/09-04/11


VAERS ID: 1401454 (history)  
Form: Version 2.0  
Age: 25.0  
Sex: Male  
Location: Vermont  
Vaccinated:2021-06-04
Onset:2021-06-04
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-06-15
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA - / 2 - / -

Administered by: Private       Purchased by: ?
Symptoms: Atrial fibrillation, Brain natriuretic peptide increased, Bronchitis, C-reactive protein increased, Computerised tomogram thorax abnormal, Condition aggravated, Cough, Dizziness, Dyspnoea, Electrocardiogram abnormal, Fibrin D dimer increased, Palpitations, Pulmonary oedema, SARS-CoV-2 test negative, Troponin, Upper respiratory tract infection, White blood cell count increased
SMQs:, Cardiac failure (narrow), Anaphylactic reaction (broad), Haemorrhage laboratory terms (broad), Neuroleptic malignant syndrome (broad), Anticholinergic syndrome (broad), Arrhythmia related investigations, signs and symptoms (broad), Supraventricular tachyarrhythmias (narrow), Acute central respiratory depression (broad), Pulmonary hypertension (broad), Haemodynamic oedema, effusions and fluid overload (narrow), Cardiomyopathy (broad), Vestibular disorders (broad), Drug reaction with eosinophilia and systemic symptoms syndrome (broad), COVID-19 (broad)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit? No
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, ? days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: No medications
Current Illness: Patient began experiencing upper respiratory tract infection symptoms approximately three days prior to receiving second dose of moderna COVID 19 vaccine on 6/4/21, this illness lasted approximately until 6/12/21 when his URI symptoms seemed to resolve. However he had persistent shortness of breath, lightheadedness, and palpitations starting around 6/12-6/13 which ultimately brought him to the emergency department on 6/15/21.
Preexisting Conditions: Described palpitations through adolescence into adulthood, but never formally diagnosed with anything. No other past medical history to date.
Allergies: No allergies to medications
Diagnostic Lab Data: Initial lab work and tests upon presentation notable for EKG with AFIB and rates in 160-200s. D Dimer 4829, troponin 0.059, CT angio of the chest demonstrating pulmonary edema. CRP 19.1, BNP 7500, WBC 13.27. COVID 19 PCR test negative. Further work up still pending.
CDC Split Type:

Write-up: Patient received second dose of Moderna COVID 19 vaccine on 6/4/21. During this same time, patient also had URI diagnosed as bronchitis at an urgent care and provided albuterol inhaler. Cough and URI symptoms subsided on approximately 6/12/21 but developed SOB, lightheadedness, and palpitations thereafter prompting presentation to ED on 6/15/21. Patient was started on digoxin, heparin, and furosemide by cardiology team. Work up in progress.


VAERS ID: 1579214 (history)  
Form: Version 2.0  
Age: 37.0  
Sex: Male  
Location: Vermont  
Vaccinated:2021-05-12
Onset:2021-05-12
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-08-17
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (PFIZER-BIONTECH)) / PFIZER/BIONTECH EW0183 / 1 LA / SYR

Administered by: Public       Purchased by: ?
Symptoms: Back pain, Computerised tomogram, Electroencephalogram, Impaired work ability, Magnetic resonance imaging, Mobility decreased, Seizure, Spinal fracture, Upper limb fracture, X-ray
SMQs:, Systemic lupus erythematosus (broad), Retroperitoneal fibrosis (broad), Convulsions (narrow), Parkinson-like events (broad), Noninfectious encephalitis (broad), Noninfectious encephalopathy/delirium (broad), Noninfectious meningitis (broad), Accidents and injuries (narrow), Osteoporosis/osteopenia (broad), Generalised convulsive seizures following immunisation (narrow), Tendinopathies and ligament disorders (broad), Hypoglycaemia (broad)

Life Threatening? Yes
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? Yes
Hospitalized? Yes, 1 days
   Extended hospital stay? No
Previous Vaccinations:
Other Medications: Lantus- 16mg/day
Current Illness:
Preexisting Conditions: Diabetes - 2 years
Allergies:
Diagnostic Lab Data: After Seizure: EEG MRI CT Scan Multiple X-Rays
CDC Split Type:

Write-up: Vaccine was administered around 12:30PM Wednesday 5/12/21. At approximately 12:34PM seizure occurred. Seizure caused fractured spine. Fractured spine resulted in loss of work/mobility. Second seizure occurred 1 month later, resulting in more back pain/fracture and broken shoulder. Had no prior neurology issues or family history with seizures. Saw a Neurologist and was prescribed Lamotrigine.


VAERS ID: 1757159 (history)  
Form: Version 2.0  
Age: 37.0  
Sex: Male  
Location: Vermont  
Vaccinated:2021-02-24
Onset:2021-02-24
   Days after vaccination:0
Submitted: 0000-00-00
Entered: 2021-10-03
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 030L20A / 1 LA / IM
COVID19: COVID19 (COVID19 (MODERNA)) / MODERNA 022MZ0A / 2 LA / ID

Administered by: Work       Purchased by: ?
Symptoms: Audiogram abnormal, Deafness neurosensory, Ear pain, Tinnitus
SMQs:, Hearing impairment (narrow)

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? Yes
Recovered? No
Office Visit? Yes
ER Visit? No
ER or Doctor Visit? No
Hospitalized? No
Previous Vaccinations:
Other Medications: Vitamin C, Vitamin D3, Zinc
Current Illness: None
Preexisting Conditions: None
Allergies: Penicillin
Diagnostic Lab Data: Audiogram on September 10th showed sensorineural hearing loss
CDC Split Type:

Write-up: tinnitus, Progressive sensorineural hearing loss, and ear ache


New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?TABLE=ON&GROUP1=AGE&EVENTS=ON&VAX=COVID19&VAXTYPES=COVID-19&SERIOUS=ON&NUMDAYS=0&STATE=VT

Government Disclaimer on use of this data


Copyright © 2021 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166